Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Policy topic
No spam. Unsubscribe anytime.
Senate committee advances amended bill on 340B hospital transparency after contentious amendments
Summary
The Senate Health and Human Services Committee voted to advance an amended version of Senate Bill 124, removing provisions that conflicted with an earlier bill and keeping reporting and enforcement sections to preserve transparency requirements for 340B program recipients.
Get email alerts on the Healthcare Policy topic
No spam. Unsubscribe anytime.
The Senate Health and Human Services Committee advanced Senate Bill 124 as amended Tuesday, sending the measure to the next stage of legislative consideration after a protracted amendment phase and divided vote.
Senator Zachary Weisman, sponsor of the amendment, said the change was intended to resolve direct conflicts between SB124 and related legislation, and to preserve key reporting and enforcement language. “With this amendment, I think that there is a lot to commend onward progress of 124 out of this committee and on to second reading,” Weisman said during the amendment discussion.
The amendment identified in committee as L‑8 removes subsections from pages described in the draft that the sponsor said conflicted with sections of an earlier bill and with the federal 340B framework. The amendment kept other sections intact, including reporting provisions and an enforcement mechanism the committee considered important to transparency.
Senator Gonzalez, who participated in negotiations, thanked members and public witnesses and emphasized a shared interest across parties in a transparent system that supports patients and preserves safety‑net hospitals. “I think we all, regardless of party, ... are trying to ensure that this system works in a fair, transparent, and ... way,” Gonzalez said on the record.
Committee debate acknowledged both policy goals and practical concerns. Supporters said the bill’s transparency and reporting pieces would help policymakers and the public understand how 340B‑derived funds are used. Opponents raised concerns that overlapping provisions and potential federal interactions could create instability for hospitals and patients if not reconciled.
After the amendment phase closed, Senator Weisman moved SB124, as amended, to the Committee of the Whole with a favorable recommendation. The committee recorded the motion and later reported the bill out with a favorable recommendation; the vote tally reported in the hearing concluded with the measure passing out of committee on a 6–3 vote.
The committee transcript shows sponsors and members committed to continued negotiation between sponsors of the competing measures so the bills can be reconciled on the floor. No floor amendments or further committee conditions were recorded at the close of the hearing.
The legislation centers on state-level reporting and limitations for non‑profit hospitals participating in the federal 340B drug discount program. Committee members repeatedly framed the discussion as balancing patient access, safety‑net hospital viability and the need for public transparency about how program‑related revenue is used.
If the bill proceeds, the committee and sponsors said they expect further work on harmonizing SB124’s remaining provisions with the related bill referenced repeatedly in the hearing record.
